These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 16618534

  • 21. Clinical overview of the taxanes.
    Goldspiel BR.
    Pharmacotherapy; 1997; 17(5 Pt 2):110S-125S. PubMed ID: 9322878
    [Abstract] [Full Text] [Related]

  • 22. Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model.
    Marchettini P, Stuart OA, Mohamed F, Yoo D, Sugarbaker PH.
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):499-503. PubMed ID: 12107555
    [Abstract] [Full Text] [Related]

  • 23. Taxanes in elderly breast cancer patients.
    Wildiers H, Paridaens R.
    Cancer Treat Rev; 2004 Jun; 30(4):333-42. PubMed ID: 15145508
    [Abstract] [Full Text] [Related]

  • 24. Hyperthermia During Intraperitoneal Chemotherapy With Paclitaxel or Docetaxel for Ovarian Cancer: Is There Any Benefit?
    de Bree E, Katsougkri D, Polioudaki H, Tsangaridou E, Michelakis D, Zoras O, Theodoropoulos P.
    Anticancer Res; 2020 Dec; 40(12):6769-6780. PubMed ID: 33288570
    [Abstract] [Full Text] [Related]

  • 25. Intraperitoneal hyperthermic chemotherapy using carboplatin: a phase I analysis in ovarian carcinoma.
    Lentz SS, Miller BE, Kucera GL, Levine EA.
    Gynecol Oncol; 2007 Jul; 106(1):207-10. PubMed ID: 17498782
    [Abstract] [Full Text] [Related]

  • 26. Improved survival trends in platinum-resistant patients with advanced ovarian, fallopian or peritoneal cancer treated with first-line paclitaxel/platinum chemotherapy: the impact of novel agents.
    Bamias A, Bamia C, Zagouri F, Kostouros E, Kakoyianni K, Rodolakis A, Vlahos G, Haidopoulos D, Thomakos N, Antsaklis A, Dimopoulos MA.
    Oncology; 2013 Jul; 84(3):158-65. PubMed ID: 23296063
    [Abstract] [Full Text] [Related]

  • 27. [Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy associated toxicity in treatment of peritoneal carcinomatosis].
    Mancebo-González A, Díaz-Carrasco MS, Cascales-Campos P, de la Rubia A, Gil Martínez J.
    Farm Hosp; 2012 Jul; 36(2):60-7. PubMed ID: 21514864
    [Abstract] [Full Text] [Related]

  • 28. An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer.
    Berry E, Matthews KS, Singh DK, Buttin BM, Lurain JR, Alvarez RD, Schink J.
    Gynecol Oncol; 2009 Apr; 113(1):63-7. PubMed ID: 19201457
    [Abstract] [Full Text] [Related]

  • 29. [Effectiveness of intraperitoneal chemotherapy using new-aged drugs for the peritoneal dissemination of gastric cancer].
    Fushida S, Fujita H, Kinami S, Ninomiya I, Fujimura T, Nishimura G, Ohta T.
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1691-4. PubMed ID: 16315911
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Perioperative fast track program in intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery in advanced ovarian cancer.
    Cascales Campos PA, Gil Martínez J, Galindo Fernández PJ, Gil Gómez E, Martínez Frutos IM, Parrilla Paricio P.
    Eur J Surg Oncol; 2011 Jun; 37(6):543-8. PubMed ID: 21489742
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The cytotoxic effect of combined hyperthermia and taxane chemotherapy on ovarian cancer cells: results of an in vitro study.
    Muller M, Chérel M, Dupré PF, Gouard S, Collet M, Classe JM.
    Eur Surg Res; 2012 Jun; 48(2):55-63. PubMed ID: 22205139
    [Abstract] [Full Text] [Related]

  • 35. Intraperitoneal paclitaxel: a possible impact of regional delivery for prevention of peritoneal carcinomatosis in patients with gastric carcinoma.
    Kodera Y, Ito Y, Ito S, Ohashi N, Mochizuki Y, Yamamura Y, Koike M, Fujiwara M, Nakanishi H, Nakao A.
    Hepatogastroenterology; 2007 Jun; 54(75):960-3. PubMed ID: 17591103
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A randomized Phase II/III trial of 3 weekly intraperitoneal versus intravenous carboplatin in combination with intravenous weekly dose-dense paclitaxel for newly diagnosed ovarian, fallopian tube and primary peritoneal cancer.
    Fujiwara K, Aotani E, Hamano T, Nagao S, Yoshikawa H, Sugiyama T, Kigawa J, Aoki D, Katsumata N, Takeuchi M, Suzuki M.
    Jpn J Clin Oncol; 2011 Feb; 41(2):278-82. PubMed ID: 20937602
    [Abstract] [Full Text] [Related]

  • 38. Docetaxel in the management of ovarian cancer.
    Blagden SP, Kaye SB.
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):203-14. PubMed ID: 15877518
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.